Unicycive Therapeutics (UNCY) Profit After Tax Growth (3y) (2023 - 2026)
Unicycive Therapeutics (UNCY) Profit After Tax Growth (3y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
33.21% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
30.60% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-154.28% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
16.53% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Unicycive Therapeutics |
159.47 Mn |
104.88 Mn |
- |
4.18% |
| Date | Value |
|---|
| Mar 31, 2026 |
4.18% |
| Dec 31, 2025 |
-40.15% |
| Sep 30, 2025 |
-2.65% |
| Jun 30, 2025 |
-21.04% |
| Mar 31, 2025 |
29.29% |
| Dec 31, 2024 |
-98.50% |
| Sep 30, 2024 |
7.65% |
| Jun 30, 2024 |
122.12% |
| Mar 31, 2024 |
-179.12% |
| Dec 31, 2023 |
-106.93% |
| Sep 30, 2023 |
-83.44% |
| Jun 30, 2023 |
-124.77% |
